Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1995
09/26/1995US5453440 Peptide mimics useful as platelet aggregation inhibitors
09/26/1995US5453420 Ethanol extract of garlic
09/26/1995US5453419 Xenopus laevis bone morphogenetic proteins and use thereof
09/26/1995US5453418 Ractopamine and growth hormone combinations
09/26/1995US5453417 Process for the phosphorylation of insulin and product produced thereby
09/26/1995US5453373 Protein C derivatives
09/26/1995US5453362 Herpes virus, viricides
09/26/1995US5453361 Method for producing biologically active human brain derived neurotrophic factor
09/26/1995US5453359 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
09/26/1995US5453354 Method for improving sperm motility
09/26/1995US5453284 Thickener prevents activation of oxidoreductase enzyme prior to application
09/26/1995US5453272 Serine-proline-tyrosine-glycine-arginine-cysteine hexapeptide; immunosuppressant
09/26/1995US5453270 Pharmaceutical composition and method for hypermetabolic weight loss
09/26/1995US5453269 Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use
09/26/1995CA1337113C Pharmaceutical composition for eliciting an immunostimulant effect
09/25/1995CA2143588A1 Inhibitors of farnesyl protein transferase
09/22/1995CA2145033A1 Cosmetic composition containing a superoxide dismutase and an associated porphyrin
09/21/1995WO1995025273A1 Methods and devices for automatic assessment of corn
09/21/1995WO1995025171A2 Dna sequences for matrix metalloproteases, their production and use
09/21/1995WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b)
09/21/1995WO1995025169A1 CHIMERIC GENE USING THE GENE OR cDNA OF INSULINE, SPECIALLY FOR THE GENE THERAPY OF DIABETES
09/21/1995WO1995025167A1 Anti-egfr single-chain fvs and anti-egfr antibodies
09/21/1995WO1995025126A1 Antibodies to interleukin-8 receptors and methods of use
09/21/1995WO1995025125A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995WO1995025124A1 Methods to diagnose and treat hiv-1 infection
09/21/1995WO1995025123A1 Peptides inhibiting the release of pepsine
09/21/1995WO1995025122A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
09/21/1995WO1995025121A1 Enhancement of antitumor therapy with hemoglobin-based conjugates
09/21/1995WO1995025118A2 Inhibitors of sh2 domain interactions
09/21/1995WO1995025117A1 Polypeptides of lipopolysaccharide binding protein
09/21/1995WO1995025092A1 Inhibitors of farnesyl-protein transferase
09/21/1995WO1995025086A1 Isoprenyl transferase inhibitors
09/21/1995WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/21/1995WO1995024927A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins
09/21/1995WO1995024922A1 Chlamydia vaccines and process
09/21/1995WO1995024921A1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
09/21/1995WO1995024920A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/21/1995WO1995024919A1 New use of growth hormone
09/21/1995WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases
09/21/1995WO1995024917A1 Skin treatment composition
09/21/1995WO1995024916A1 Retropeptides, antibodies thereto, and uses thereof for vaccination and in vitro diagnosis
09/21/1995WO1995024915A1 Product and process for regulating signal transduction pathways
09/21/1995WO1995024914A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/21/1995WO1995024913A1 Treatment of graft-versus-host disease
09/21/1995WO1995024912A1 METHODS OF MODULATING INFLAMMATORY CYTOKINES IN THE CNS USING TGF-$g(b)
09/21/1995WO1995024910A1 Immunotherapy of cancer with allogeneic lymphocytes
09/21/1995WO1995024908A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders
09/21/1995WO1995024906A1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
09/21/1995WO1995024904A1 Synergistic inhibition of hiv-1 infection using a nucleoside reverse transcriptase inhibitor and anti-hiv-1 antibodies
09/21/1995WO1995024898A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
09/21/1995WO1995024897A1 Anti-viral and anti-cancer agents
09/21/1995WO1995024890A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide
09/21/1995WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
09/21/1995WO1995018826A3 Purified primate ctla-8 antigens and related reagents
09/21/1995CA2185817A1 Anti-viral and anti-cancer agents
09/21/1995CA2185724A1 Methods of modulating inflammatory cytokines in the cns using tgf-.beta.
09/21/1995CA2185690A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide
09/21/1995CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/21/1995CA2185553A1 Inhibitors of farnesyl-protein transferase
09/21/1995CA2185441A1 Isoprenyl transferase inhibitors
09/21/1995CA2185433A1 Enhancement of antitumor therapy with hemoglobin-based conjugates
09/21/1995CA2185425A1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
09/21/1995CA2185341A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995CA2185326A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/21/1995CA2185324A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/21/1995CA2185129A1 Methods to diagnose and treat hiv-1 infection
09/21/1995CA2184753A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
09/21/1995CA2184631A1 Product and process for regulating signal transduction pathways
09/21/1995CA2184352A1 Immunotherapy of cancer with allogeneic lymphocytes
09/21/1995CA2184269A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins
09/21/1995CA2181162A1 Skin treatment composition
09/20/1995EP0672684A1 Novel megakaryocyte colony stimulating factor and production thereof
09/20/1995EP0672683A1 Macif protein, genes coding therefor, expression vectors containing said genes, and transformant cells containing said protein
09/20/1995EP0672682A1 hPTH(1-36) peptides, their preparation and pharmaceutical compositions
09/20/1995EP0672681A1 Novel antitumor peptide
09/20/1995EP0672680A1 Novel peptide
09/20/1995EP0672679A1 Phospholipase c inhibiting peptide
09/20/1995EP0672678A1 Azapeptide derivative
09/20/1995EP0672665A1 Antithrombotic agents
09/20/1995EP0672659A1 Antithrombotic agents
09/20/1995EP0672658A1 Antithrombotic agents
09/20/1995EP0672657A1 Antithrombotic agents
09/20/1995EP0672648A1 Threo-3-amino-2-hydroxypentanoic acid and threo (2R,3S), (2S,3R)-3-(p-methoxy-benzyloxycarbonyl) amino-2-hydroxy-pentanoic acid
09/20/1995EP0672421A1 Endothelin activity inhibitor
09/20/1995EP0672420A1 Wound remedy
09/20/1995EP0672419A1 Blood pressure regulator
09/20/1995EP0672418A2 Use of adenosine monophosphate deaminase inhibitor for increasing extracellular adenosine
09/20/1995EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
09/20/1995EP0672193A1 Oligonucleotides having a conserved g 4? core sequence
09/20/1995EP0672192A1 Method for inhibition of viral morphogenesis
09/20/1995EP0672180A1 Oligonucleotide modulation of protein kinase c
09/20/1995EP0672178A1 Oligonucleotide modulation of cell growth
09/20/1995EP0672160A1 Activating expression of an amplifying endogenous gene by homologous recombination
09/20/1995EP0672159A1 In vivo homologous sequence targeting in eukaryotic cells
09/20/1995EP0672158A1 Virus with modified binding moiety specific for the target cells
09/20/1995EP0672153A1 Vector to deliver and express foreign gene
09/20/1995EP0672152A1 Fusion proteins comprising mgf and il-3
09/20/1995EP0672151A1 Inhibitors of ced-3 and related proteins
09/20/1995EP0672147A1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria
09/20/1995EP0672145A1 Interleukin-3 (il-3) multiple mutation polypeptides
1 ... 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 ... 3163